Analytical Data
-
基因名
PB000185.00.0
- Application
-
别名
PB000185.00.0; L-lactate dehydrogenase; EC 1.1.1.27
-
种属
Plasmodium berghei
-
表达系统
E. coli
-
标签
N- His & C- Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q7SI97
-
表达区间
1-316aa
-
分子量
39.4 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PB000185.00.0 is a recombinant protein that has garnered attention in biomedical research due to its potential applications in therapeutic and diagnostic fields. The study of this protein is driven by the need to understand its functional role in cellular processes, particularly in relation to disease states such as cancer and metabolic disorders. Recombinant proteins like PB000185.00.0 are produced using genetic engineering techniques, allowing for large-scale production and purification, which is crucial for various experimental applications. Investigating the structure-function relationship of PB000185.00.0 may reveal insights into its mechanism of action, enabling researchers to design targeted interventions or enhance existing treatment modalities. Moreover, the protein’s characteristics may also aid in the development of more reliable biomarkers for disease diagnosis and prognosis. Overall, the research surrounding PB000185.00.0 is pivotal as it not only contributes to our fundamental understanding of molecular biology but also holds promise for advancing clinical practices and improving patient outcomes.
